Allergan Plc

( )
AGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Generic
AGNAllergan Plc 1.48%177.482.9%$883.39m
ZTSZoetis, Inc. 3.73%116.091.9%$450.79m
TEVATeva Pharmaceutical Industries Ltd. -4.25%8.112.0%$197.32m
MYLMylan NV -2.38%13.923.2%$134.33m
BBIOBridgeBio Pharma, Inc. -1.36%24.740.0%$44.03m
RDYDr. Reddy's Laboratories Ltd. 2.35%40.482.0%$9.52m
TXMDTherapeuticsMD, Inc. 0.22%1.0022.2%$4.32m
TAROTaro Pharmaceutical Industries Ltd. 1.36%62.506.5%$4.01m
COCPCocrystal Pharma, Inc. 3.64%0.720.0%$3.86m
ABEOAbeona Therapeutics, Inc. 6.03%2.114.5%$3.43m
LFVNLifeVantage Corp. 2.24%10.483.3%$1.15m
KINKindred Biosciences, Inc. 9.71%3.840.3%$1.01m
CPHIChina Pharma Holdings, Inc. -8.83%0.410.1%$0.80m
JAGXJaguar Health, Inc. -4.16%0.482.2%$0.16m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.